Clinical Benefits and Safety of FMS-Like Tyrosine Kinase 3 Inhibitors in Various Treatment Stages of Acute Myeloid Leukemia: A Systematic Review, Meta-Analysis, and Network Meta-Analysis

Overview of attention for article published in Frontiers in oncology, June 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 23 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 14,887 followers.

RT @tyrkinasepapers: Clinical Benefits and Safety of FMS-Like Tyrosine Kinase 3 Inhibitors in Various Treatment Stages of Acute Myeloid Leu…

22 Jun 2021

Reply Repost Favourite

Clinical Benefits and Safety of FMS-Like Tyrosine Kinase 3 Inhibitors in Various Treatment Stages of Acute Myeloid Leukemia: A Systematic Review, Meta-Analysis, and Network Meta-Analysis https://t.co/GSUqespXtx

22 Jun 2021

Reply Repost Favourite

New article: Clinical Benefits and Safety of FMS-Like Tyrosine Kinase 3 Inhibitors in Various Treatment Stages of Acute Myeloid Leukemia: A Systematic Review, Meta-Analysis, and Network Meta-Analysis https://t.co/8z9WnFAB8c #AML #leusm #hematology https://

21 Jun 2021

Reply Repost Favourite

New research: Clinical Benefits and Safety of FMS-Like Tyrosine Kinase 3 Inhibitors in Various Treatment Stages of Acute Myeloid Leukemia: A Systematic Review, Meta-Analysis, and Network Meta-Analysis: Background Given the controversial roles… https://t.co

03 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.